Utah legislation · 2026 General Session
Utah SB96: Opioid Fatality Review Amendments
Status: Signed into law, March 17, 2026
This bill amends provisions related to the investigation and prevention opioid fatalities.
What the bill says
From the enrolled text, March 5, 2026:
0 Opioid Fatality Review Amendments 2026 GENERAL SESSION STATE OF UTAH Chief Sponsor: Jen Plumb House Sponsor: Matthew H. Gwynn LONG TITLE General Description: This bill amends provisions related to the investigation and prevention of opioid fatalities. Highlighted Provisions: This bill: - clarifies the Department of Health and Human Services' (department) authority to investigate and control health hazards which may affect the public including the authority to investigate and control drug overdose and drug overdose fatalities; - specifies that the disclosure and redisclosure of substance use disorder treatment records provided to the medical examiner as requested for a death investigation are subject to certain federal laws; - provides that the department may use the department's authority to identify opportunities for prevention, intervention, and postvention of deaths under the medical examiner's jurisdiction; and - defines terms. Money Appropriated in this Bill: None Other Special Clauses: None Utah Code Sections Affected: AMENDS: 26B-7-202 , as last amended by Laws of Utah 2025, Chapter 109 26B-8-211 , as renumbered and amended by Laws of Utah 2023, Chapter 306 26B-8-222 , as renumbered and amended by Laws of Utah 2023, Chapter 306 Be it enacted by the Legislature of the state of Utah: Section 1. Section 26B-7-202 is amended to read: 26B-7-202 . Authority to investigate and control epidemic infections and communicable disease. (1) …
Sponsors
- Plumb, Jen (D, 9) · primary sponsor
- Gwynn, Matthew H. (R, 6)
Latest actions
- : Governor Signed
- : Senate/ to Governor
- : Senate/ received enrolled bill from Printing
- : Senate/ enrolled bill to Printing
- : Enrolled Bill Returned to House or Senate
- : Draft of Enrolled Bill Prepared
- : Bill Received from Senate for Enrolling
- : Senate/ signed by President/ sent for enrolling
- : Senate/ received from House
- : House/ to Senate
Votes
- House/ passed 3rd reading (February 26, 2026): 62 yea, 0 nay, passed
- House Comm - Favorable Recommendation (February 24, 2026): 11 yea, 0 nay, passed
- Senate/ passed 3rd reading (February 3, 2026): 23 yea, 0 nay, passed
- Senate/ passed 2nd reading (February 2, 2026): 28 yea, 0 nay, passed
- Senate Comm - Substitute Recommendation (January 21, 2026): 5 yea, 0 nay, passed
- Senate Comm - Favorable Recommendation (January 21, 2026): 5 yea, 0 nay, passed
Subjects: Health Care, Health and Human Services, Medical Records, Fatality Reports, Controlled Substances, Public Health, Substance Abuse, Department of Health and Human Services
Common questions
- What is SB96?
- SB96 is a bill in the Utah Legislature (2026 General Session): Opioid Fatality Review Amendments.
- What does SB96 do?
- This bill amends provisions related to the investigation and prevention opioid fatalities.
- What is the status of SB96?
- Signed into law as of March 17, 2026. Latest action: Governor Signed (March 17, 2026).
- Who sponsored SB96?
- Plumb, Jen (D, 9), with 1 co-sponsor.
- Where is the official record for SB96?
- On the Utah Legislature website: https://le.utah.gov/~2026/bills/static/SB0096.html
Source: official Utah record. Tracked by Delilah, AI for legislation across all 50 states and Congress.